|
Market Closed -
Nasdaq
04:00:00 28/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 159.08 USD | +0.25% |
|
+1.64% | +29.61% |
| 10-28 | Gilead Sciences Inc Announces National Agreement for LYVDELZI Seladelpar for Primary Biliary Cholangitis in Canada | CI |
| 10-26 | AstraZeneca Readies New Portfolio of Targeted Cancer Therapies | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.25% | +1.64% | +5.40% | +21.88% | +29.61% | +32.05% | +107.62% | +138.25% | +109.79% | 197B | |
| +0.22% | -0.14% | +8.32% | +7.05% | +19.28% | +55.12% | +128.82% | +412.42% | +1,583.18% | 1,143B | |
| +0.91% | +3.61% | -0.92% | +1.05% | +29.85% | +41.21% | +84.57% | +64.12% | +132.26% | 647B | |
| -0.12% | -0.93% | +8.34% | +11.47% | +25.34% | +25.59% | +106.14% | +164.20% | +365.98% | 506B | |
| -1.28% | +0.48% | +10.83% | +7.07% | +20.02% | +50.86% | +63.24% | +10.40% | +71.41% | 384B | |
| +0.86% | -4.37% | -4.68% | +8.46% | +34.73% | +61.16% | +37.93% | +73.93% | +131.39% | 350B | |
| 0.00% | +1.29% | +5.86% | -1.44% | +17.26% | +29.99% | +51.86% | +67.96% | +80.76% | 293B | |
| -0.67% | +0.84% | +1.83% | -1.70% | -7.76% | +2.53% | +24.49% | +40.40% | +175.50% | 265B | |
| +0.75% | +2.05% | +8.04% | +19.05% | +36.86% | +53.85% | +71.25% | +116.84% | +178.97% | 242B | |
| -1.24% | -2.06% | +1.61% | -23.58% | -21.20% | -22.64% | -62.18% | -25.68% | +115.83% | 171B | |
| +0.03% | -1.03% | +3.94% | +20.79% | +19.68% | +20.31% | -1.03% | -30.65% | -8.25% | 170B | |
| +0.68% | +1.24% | -0.98% | +8.77% | +14.93% | +24.00% | +46.65% | +187.96% | +587.01% | 132B | |
| -0.10% | -0.21% | -2.08% | -1.61% | +14.11% | +41.85% | +20.64% | +8.96% | +18.46% | 126B | |
| -2.60% | -6.13% | +11.58% | +13.76% | +17.89% | +19.17% | +115.84% | +376.29% | +502.50% | 113B | |
| -5.67% | -3.08% | -2.66% | -10.77% | -0.77% | +10.13% | +24.66% | -3.38% | -11.00% | 103B | |
| +0.13% | +2.28% | +4.51% | -5.20% | -9.03% | -13.75% | -10.57% | -12.49% | +5.35% | 100B | |
| +1.04% | +1.07% | +3.56% | +22.32% | +5.73% | +39.43% | +5.28% | +38.42% | +123.37% | 81.49B | |
| +4.59% | -14.09% | +4.57% | +273.85% | +605.22% | +680.08% | +189.21% | -38.99% | - | 83.03B | |
| -1.11% | +1.58% | +3.96% | -5.50% | -19.76% | -4.05% | +51.98% | +55.77% | +451.93% | 69.7B | |
| +0.42% | +2.14% | +4.95% | +0.73% | +18.52% | +28.02% | +5.40% | -29.26% | +54.16% | 70B | |
| Average | -0.86% | -0.22% | +3.80% | +18.32% | +42.53% | +58.75% | +53.09% | +80.77% | +245.72% | 262.31B | |
| Weighted average by Cap. | -0.92% | +0.31% | +4.61% | +10.08% | +28.01% | +46.43% | +73.58% | +146.93% | +481.89% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
